Moxifloxacin Ophthalmic Solution
Failed Impurities/Degradation Specifications
11,818 recalls · Class II, newest first
Failed Impurities/Degradation Specifications
Failed Dissolution Specifications.
cGMP deviations
Lack of Assurance of Sterility
Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.
CGMP Deviations
Failed Stability Specifications
Subpotent Drug: Out of specification for assay at the 30-month stability timepoint.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Complaint received of foreign matter (metal) embedded in tablet.
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Superpotent and Failed Tablet/Capsule Specifications
Failed Impurities/Degradation Specifications
CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Defective Delivery System
Failed impurities/degradation specifications
Failed Dissolution Specifications
Subpotent
Defective Container: The notch in the cap that fits into the nozzle of the dropper could break off and block the dropper possibly resulting in the product not dispensing.
Defective Container: Leaking containers.
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations